Waltham, MA – October 9th, 2020 – Bigtincan, the global leader in sales enablement automation, announced the acquisition of Agnitio A/S the maker of the Rainmaker SaaS platform that delivers e-detailing and digital sales room experiences for leading global enterprise customers, adding to Bigtincan’s existing leadership in sales enablement for the Life Sciences.
Bigtincan provides organizations with a complete, intelligent platform to onboard sellers faster, help sellers find the right assets, automatically personalize content, and measure results in real-time. Agnitio’s specialized technology facilitates remote and in-person interactions with healthcare providers delivering key medical assets in a secure, fully compliant environment.
“Agnitio is a top-tier life sciences-focused software company with amazing people and passionate customers.” said David Keane, CEO of Bigtincan. “Digital Sales Rooms are game-changers transforming the way companies interact with the modern healthcare professionals in our increasingly remote business environment.”
“We are really excited to be part of the Bigtincan family. Bigtincan is on a fantastic journey and has set high standards for intelligent, automated sales enablement with an impressive cross-industry customer base” said Lars Meincke, CEO of Agnitio. “They have also proven incredibly good at integrating other companies and their unique capabilities. This means completely new opportunities for speeding up development of our sales enablement and remote capabilities – and further strengthening the support we’re offering to life science companies.”
As part of Bigtincan, Agnitio will be positioned to strengthen its deep focus on life sciences, adding key capabilities, scale, and security to the platform. Agnitio brings a strong customer base including major Pharma companies who rely on Agnitio to facilitate interactions across 45 countries.
With its headquarters in Copenhagen, Agnitio expands Bigtincan’s European presence with an expert team of product specialists and developers. Agnitio is Bigtincan’s seventh acquisition since 2017, following XINN late last year.
Bigtincan (ASX:BTH) helps sales and service teams increase win rates and customer satisfaction. The company’s AI-powered sales enablement automation platform leading the sales enablement market, features the industry’s premier user experience that empowers reps to more effectively engage with customers and prospects and encourages team-wide adoption. Leading brands including AT&T, Thermo Fisher, Merck, ANZ Bank and others rely on Bigtincan to enhance sales productivity and fuel customer engagement. With global sales and marketing headquartered in Boston, Bigtincan also has offices across EMEA, Australia and Asia. To discover more about how your organization can benefit from the Bigtincan platform, please visit www.bigtincan.com or follow @bigtincan on Twitter.
Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals. The provider of the leading pull marketing software platform for the pharmaceutical and medical device industries, Agnitio’s system is already implemented in more than 45 countries and 25 languages – and used by major pharmaceutical and medical device companies. Please visit www.agnitio.com to read more about Agnitio’s remote and sales enablement technologies.